• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY TORIC EXTENDED VISION IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY TORIC EXTENDED VISION IOL; INTRAOCULAR LENS Back to Search Results
Model Number DFT315
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Macular Edema (1822)
Date of Event 07/01/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The product was not returned for analysis; the lens remains implanted.Complaint history and product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A healthcare professional reported that the patient had sought a second opinion.Additional information has been requested and received stating that the patient developed macular edema.A fluorescent angiography (fag) was ordered.The patient decided to see another ophthalmologist.The fluorescent angiography (fag) was then performed at a different eye center.Lens remain implanted in the eye.
 
Additional Manufacturer Narrative
Additional information has been provided in b.5., and h.11.Based on information received following submission of the initial report, this event does not meet criteria for reporting as a serious injury/malfunction.No further reports required.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
Additional information has been received, and file was reassessed as it was noted that the macular edema had nothing to do with the iol.It was a case of age-related macular degeneration.It has been determined that there is no reported complaint or defect with the product.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ VIVITY TORIC EXTENDED VISION IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
246 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
246 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key23050582
Report Number1119421-2025-02468
Device Sequence Number13139671
Product Code POE
UDI-Device Identifier00380652421638
UDI-Public(01)00380652421638(17)270227(11)220301(10)15363129
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/15/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberDFT315
Device Catalogue NumberDFT315.195
Device Lot Number15363129
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 08/21/2025
Supplement Date Received by Manufacturer09/16/2025
Initial Report FDA Received Date09/15/2025
Supplement Report FDA Received Date10/15/2025
Date Device Manufactured03/01/2022
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
MONARCH III IOL, CARTRIDGE D; MONARCH III IOL, INJECTOR
Outcome Attributed to Adverse Event Other;
Patient Age79 YR
Patient SexFemale
-
-